{ "@context": "https://schema.org", "@graph": [ { "@type" : "Organization", "@id": "/#Organization", "name": "Jornal Correio de Santa Maria", "url": "/", "logo": "/images/1475677208Principal-site2.png", "sameAs": ["https:\/\/www.facebook.com\/correiodesantamaria\/","social_button_instagram_url"] }, { "@type": "BreadcrumbList", "@id": "/#Breadcrumb", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Jornal Correio de Santa Maria", "item": "/" }, { "@type": "ListItem", "position": 2, "name": "Brasil", "item": "/ver-noticia/125/brasil" }, { "@type": "ListItem", "position": 3, "name": "Anvisa autoriza uso do Mounjaro no tratamento da obesidade" } ] }, { "@type" : "Website", "@id": "/noticia/28716/anvisa-autoriza-uso-mounjaro-tratamento-obesidade#Website", "name" : "Anvisa autoriza uso do Mounjaro no tratamento da obesidade", "description": "Antes ao controle do diabetes tipo 2, medicamento agora também poderá ser prescrito para perda de peso associada à comorbidades", "image" : "/images/noticias/28716/10063638_Capturar.JPG", "url" : "/noticia/28716/anvisa-autoriza-uso-mounjaro-tratamento-obesidade" }, { "@type": "NewsMediaOrganization", "@id": "/noticia/28716/anvisa-autoriza-uso-mounjaro-tratamento-obesidade#NewsMediaOrganization", "name": "Jornal Correio de Santa Maria", "alternateName": "Jornal Correio de Santa Maria", "url": "/", "logo": "src=\", "sameAs": ["https:\/\/www.facebook.com\/correiodesantamaria\/","social_button_instagram_url"] }, { "@type": "NewsArticle", "@id": "/noticia/28716/anvisa-autoriza-uso-mounjaro-tratamento-obesidade#NewsArticle", "mainEntityOfPage": { "@type": "WebPage", "@id": "/noticia/28716/anvisa-autoriza-uso-mounjaro-tratamento-obesidade" }, "headline": "Anvisa autoriza uso do Mounjaro no tratamento da obesidade", "description": "Antes ao controle do diabetes tipo 2, medicamento agora também poderá ser prescrito para perda de peso associada à comorbidades", "image": ["/images/noticias/28716/10063638_Capturar.JPG"], "datePublished": "2025-06-10T07:35:30-03:00", "dateModified": "2025-06-10T07:35:30-03:00", "author": { "@type": "Person", "name": "correiodesantamaria-br.noticiasdoriogrande.com", "url": "/" }, "publisher": { "@type": "Organization", "@id": "/#Organization", "name": "Jornal Correio de Santa Maria", "logo": { "@type": "ImageObject", "url": "src=\", "width": 600, "height": 600 } } } ] }body { font-family: Arial; letter-spacing:-0.04em; } /* Render 2025-06-12 10:28:09 */ /* ##################### BOX NCAT125 */ /*NOVO BOX - 9*/ .box9_idnoticia_NCAT125{width:100%;height:auto;display:block;float:left;padding:40px 5px;margin:0;border-bottom:solid 1px rgba(0,0,0,0.20);}.box9_idnoticia_NCAT125 #col-img{margin:0;padding:0;}@media screen and (min-width:768px){}.box9_idnoticia_NCAT125 a:hover *{color:rgba(59,59,59,1);text-decoration:none;}.box9_idnoticia_NCAT125 .img_shadow img{background-color:#555;box-shadow:0 1px 2px rgba(0,0,0,0.4);border-radius:8px;text-align:center;width:100%;}.box9_idnoticia_NCAT125 .img_shadow .shadow{background:-webkit-gradient(linear,left top,left bottom,color-stop(0%,rgba(255,255,255,0)),color-stop(29%,rgba(255,255,255,0.01)),color-stop(30%,rgba(0,0,0,0.01)),color-stop(33%,rgba(0,0,0,0.01)),color-stop(62%,rgba(0,0,0,0.17)),color-stop(68%,rgba(0,0,0,0.24)),color-stop(90%,rgba(0,0,0,0.62)),color-stop(100%,rgba(0,0,0,0.73)));background:-webkit-linear-gradient(top,rgba(255,255,255,0) 0%,rgba(255,255,255,0.01) 29%,rgba(0,0,0,0.01) 30%,rgba(0,0,0,0.01) 33%,rgba(0,0,0,0.17) 62%,rgba(0,0,0,0.24) 68%,rgba(0,0,0,0.62) 90%,rgba(0,0,0,0.73) 100%);background:linear-gradient(to bottom,rgba(255,255,255,0) 0%,rgba(255,255,255,0.01) 29%,rgba(0,0,0,0.01) 30%,rgba(0,0,0,0.01) 33%,rgba(0,0,0,0.17) 62%,rgba(0,0,0,0.24) 68%,rgba(0,0,0,0.62) 90%,rgba(0,0,0,0.73) 100%);border-radius:5px;bottom:0;left:0;position:absolute;right:0;top:0;}.box9_minititleNCAT125{color:rgba(126,121,121,1);font-size:1.0em;font-weight:bold;float:left;display:block;width:100%;padding:0;margin:0 0 3px 0;}.box9_tituloNCAT125 h2{width:100%;display:block;font-size:1.8em !important;line-height:32px !important;font-weight:bold;padding:0;margin:0 0 2px 0;margin:0;float:left;text-decoration:inherit;color:rgba(59,59,59,1);}.box9_subtituloNCAT125{width:100%;display:block;font-size:1.2em;float:left;margin:0 0 12px 0;color:rgba(114,114,114,1);}.box9_dataNCAT125{text-transform:uppercase;color:rgba(162,161,161,1);font-size:12px;font-weight:bold;float:left;display:block;width:100%;}/*BOX 2 - SOMBRAS*/ .box_2_contentNCAT125{width:100%;height:auto;display:block;float:left;padding:0;}.box_2_contentNCAT125 .box_primary{margin-right:10px;}.box_2_contentNCAT125 .box_secundary{margin-left:10px;margin-right:0;}.box_2_contentNCAT125 #col-img{margin:0;padding:0;}.box_2_contentNCAT125 .box_4_m img{height:280px;}.box_2_contentNCAT125 .box_4_m:nth-child(1){padding-right:20px;padding-left:0;}.box_2_contentNCAT125 .box_4_m:nth-child(2){padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_4_m:nth-child(3){padding-right:20px;padding-left:0;}.box_2_contentNCAT125 .box_4_m:nth-child(4){padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_6_m img{height:240px;}.box_2_contentNCAT125 .box_6_m{padding-left:5px;}.box_2_contentNCAT125 .box_6_m:first-child{padding-left:0;}.box_2_contentNCAT125 .box_6_m:last-child{padding-right:0;}.box_2_contentNCAT125 .box_6_m:nth-child(3){padding-right:0;}.box_2_contentNCAT125 .box_6_m:nth-child(4){padding-left:0;}.box_2NCAT125{border-radius:5px;color:#fff;display:block;position:relative;text-align:center;text-shadow:0 1px #000;margin:0 0 20px 0;overflow:hidden;}.box_2NCAT125:hover{display:block;}.box_2NCAT125 img{background-color:#555;box-shadow:0 1px 2px rgba(0,0,0,0.4);border-radius:5px;text-align:center;width:100%;-moz-transition:all 0.3s;-webkit-transition:all 0.3s;transition:all 0.3s;}.box_2NCAT125:hover img{-moz-transform:scale(1.1);-webkit-transform:scale(1.1);transform:scale(1.1);}.box_2NCAT125 .shadow{background:-webkit-linear-gradient(bottom,rgba(0,0,0,0.8) 0%,transparent 100%);background:-moz-linear-gradient(bottom,rgba(0,0,0,0.8) 0%,transparent 100%);background:-ms-linear-gradient(bottom,rgba(0,0,0,0.8) 0%,transparent 100%);background:-o-linear-gradient(bottom,rgba(0,0,0,0.8) 0%,transparent 100%);background:linear-gradient(bottom,rgba(0,0,0,0.8) 0%,transparent 100%);border-radius:5px;bottom:0;left:0;position:absolute;right:0;top:0;}.box_2NCAT125 .box_2_info{bottom:37px;left:0;margin:0 0 -17px;padding:0;position:absolute;right:0;text-align:left;}.box_2NCAT125 .divider{border-bottom:1px solid rgba(255,255,255,0.5);}.box_2NCAT125 .minititle{top:10px;left:0;margin:0 0 0 10px;padding:0;position:absolute;right:0;font-size:1.1em;font-weight:normal;text-align:left;letter-spacing:none;text-transform:uppercase;color:#ffffff;}.box_2NCAT125 .title_2x{bottom:46px;font-size:2.4em;font-weight:bold;margin:0 0 8px 0;text-align:left;padding:0 10px;letter-spacing:none;color:#ffffff;}.box_2NCAT125 .title_0x{bottom:46px;font-size:1.2em;font-weight:bold;margin:0 0 8px 0;text-align:left;padding:0 10px;letter-spacing:none;color:#ffffff;}.box_2NCAT125 .title{bottom:46px;font-size:1.6em;font-weight:bold;margin:0 0 8px 0;text-align:left;padding:0 10px;letter-spacing:none;color:#ffffff;}.box_2NCAT125 .description_2x{font-size:1.1em;text-align:left;padding:0 10px;letter-spacing:none;margin:8px 0 8px 0;color:rgba(255,255,255,1);}.box_2NCAT125 .description{font-size:1.0em;text-align:left;padding:0 10px;letter-spacing:none;margin:8px 0 8px 0;color:rgba(255,255,255,1);}.box_2NCAT125 .bg-hover{background:#fff;background:rgba(255,255,255,0.9);border-radius:5px;bottom:0;left:0;opacity:0;filter:alpha(opacity=0);position:absolute;right:0;top:0;-webkit-transition:all .2s ease-out;transition:all .2s ease-out;}/* FULL BREADCRUMB */ .breadcrumb-wrapperNCAT125{background-image:-webkit-gradient(linear,left 0%,left 100%,from(rgba(59,59,59,1)),to(rgba(59,59,59,1)));background-image:-webkit-linear-gradient(top,rgba(59,59,59,1) 0%,rgba(59,59,59,1) 100%);background-image:-moz-linear-gradient(top,rgba(59,59,59,1) 0%,rgba(59,59,59,1) 100%);background-image:linear-gradient(to bottom,rgba(59,59,59,1) 0%,rgba(59,59,59,1) 100%);background-repeat:repeat-x;filter:progid:DXImageTransform.Microsoft.gradient(startColorstr="rgba(59,59,59,1)",endColorstr="rgba(59,59,59,1)",GradientType=0);color:rgba(255,255,255,1);padding:5px 0;margin:0;float:left;width:100%;display:block;text-shadow:1px 1px 0 rgba(0,0,0,0.15);z-index:2;}@media (max-width:767px){.breadcrumb-wrapperNCAT125{padding:2px 0;}.breadcrumb-wrapperNCAT125 h1,.breadcrumb-wrapperNCAT125 h2{font-size:20px !important;line-height:30px !important;}}.breadcrumb-wrapperNCAT125 .breadcrump_view{padding:10px 0;}.breadcrumb-wrapperNCAT125 h1,.breadcrumb-wrapperNCAT125 h2{font-size:1.8em;margin:0;color:rgba(255,255,255,1);padding:0;text-transform:uppercase;text-align:center;line-height:50px;}.breadcrumb-wrapperNCAT125 .breadcrumb{float:right;margin:0;border-radius:0;background-color:transparent;padding:0;}.breadcrumb-wrapperNCAT125 .breadcrumb > li{font-size:12px;font-weight:600;line-height:50px;}.breadcrumb-wrapperNCAT125 .breadcrumb > li a{color:rgba(255,255,255,1);}.breadcrumb-wrapperNCAT125 .breadcrumb > li a:hover{color:rgba(255,255,255,1);}.breadcrumb-wrapperNCAT125 .breadcrumb > .active{color:rgba(255,255,255,0.60);}.breadcrumb-wrapperNCAT125 .breadcrumb > li + li:before{color:rgba(255,255,255,1) !important;content:"\f101";padding:0 8px;display:inline-block;font-family:FontAwesome;font-style:normal;font-weight:normal;line-height:1;}/*RESPONSIVE*/ /* Tablet Portrait (768px) */ @media only screen and (min-width:321px) and (max-width:1024px) and (orientation:portrait){.box_2_contentNCAT125 .box_primary{margin-right:0;}.box_2_contentNCAT125 .box_4_m img{height:auto;}.box_2_contentNCAT125 .box_4_m:nth-child(1){padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_4_m:nth-child(2){padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_4_m:nth-child(3){padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_4_m:nth-child(4){padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_6_m img{height:auto;}.box_2_contentNCAT125 .box_6_m{padding-left:0;padding-right:0;}.box_2_contentNCAT125 .box_6_m:first-child{padding-left:0;padding-right:0;}.box_2_contentNCAT125 .box_6_m:last-child{padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_6_m:nth-child(3){padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_6_m:nth-child(4){padding-left:0;padding-right:0;}}/* Phone Landscape (480px) */ @media only screen and (min-width:321px) and (max-width:480px) and (orientation:landscape){.box_2NCAT125 .minititle{display:none;}.box_2NCAT125 .title_2x{font-size:1.2em;}.box_2NCAT125 .title_0x{font-size:0.9em;}.box_2NCAT125 .title{font-size:1.0em;}.box_2NCAT125 .description_2x{font-size:11px;}.box_2NCAT125 .description{font-size:11px;}.box_2_contentNCAT125 .box_primary{margin-right:0;}.box_2_contentNCAT125 .box_4_m img{height:auto;}.box_2_contentNCAT125 .box_4_m:nth-child(1){padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_4_m:nth-child(2){padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_4_m:nth-child(3){padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_4_m:nth-child(4){padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_6_m img{height:auto;}.box_2_contentNCAT125 .box_6_m{padding-left:0;padding-right:0;}.box_2_contentNCAT125 .box_6_m:first-child{padding-left:0;padding-right:0;}.box_2_contentNCAT125 .box_6_m:last-child{padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_6_m:nth-child(3){padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_6_m:nth-child(4){padding-left:0;padding-right:0;}}/* Phone Portrait (320px) */ @media only screen and (max-width:320px){.box_2NCAT125 .minititle{display:none;}.box_2NCAT125 .title_2x{font-size:1.2em;}.box_2NCAT125 .title_0x{font-size:0.9em;}.box_2NCAT125 .title{font-size:1.0em;}.box_2NCAT125 .description_2x{font-size:11px;}.box_2NCAT125 .description{font-size:11px;}.box_2_contentNCAT125 .box_primary{margin-right:0;}.box_2_contentNCAT125 .box_4_m img{height:auto;}.box_2_contentNCAT125 .box_4_m:nth-child(1){padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_4_m:nth-child(2){padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_4_m:nth-child(3){padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_4_m:nth-child(4){padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_6_m img{height:auto;}.box_2_contentNCAT125 .box_6_m{padding-left:0;padding-right:0;}.box_2_contentNCAT125 .box_6_m:first-child{padding-left:0;padding-right:0;}.box_2_contentNCAT125 .box_6_m:last-child{padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_6_m:nth-child(3){padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_6_m:nth-child(4){padding-left:0;padding-right:0;}}@media only screen and (max-width:420px){.box_2NCAT125 .minititle{display:none;}.box_2NCAT125 .title_2x{font-size:1.2em;}.box_2NCAT125 .title_0x{font-size:0.9em;}.box_2NCAT125 .title{font-size:1.0em;}.box_2NCAT125 .description_2x{font-size:10px;}.box_2NCAT125 .description{font-size:10px;}.box_2_contentNCAT125 .box_primary{margin-right:0;}.box_2_contentNCAT125 .box_4_m img{height:auto;}.box_2_contentNCAT125 .box_4_m:nth-child(1){padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_4_m:nth-child(2){padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_4_m:nth-child(3){padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_4_m:nth-child(4){padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_6_m img{height:auto;}.box_2_contentNCAT125 .box_6_m{padding-left:0;padding-right:0;}.box_2_contentNCAT125 .box_6_m:first-child{padding-left:0;padding-right:0;}.box_2_contentNCAT125 .box_6_m:last-child{padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_6_m:nth-child(3){padding-right:0;padding-left:0;}.box_2_contentNCAT125 .box_6_m:nth-child(4){padding-left:0;padding-right:0;}}/*END*/ window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-TEL2GLL1MT'); VideoAds = { play: function(id){ var videoSrc = document.querySelector(id); videoSrc.muted = true; videoSrc.loop = true; videoSrc.play(); }, pause: function(id){ var videoSrc = document.querySelector(id); videoSrc.loop = true; videoSrc.muted = true; videoSrc.pause(); } } 5t2468
A Agência Nacional de Vigilância Sanitária (Anvisa) aprovou, nesta segunda-feira (9/6), o uso do medicamento Mounjaro (tirzepatida) para o tratamento da obesidade. Até então, o remédio era autorizado no Brasil apenas para pacientes com diabetes tipo 2. A decisão foi publicada no Diário Oficial da União e amplia as possibilidades terapêuticas para pessoas com sobrepeso e doenças associadas.
O Mounjaro é uma caneta injetável de aplicação semanal que já estava disponível no país desde maio. Concorrente direto do Ozempic (semaglutida), o remédio pertence à farmacêutica Lilly e se destaca por agir em dois hormônios responsáveis pela regulação do apetite e da glicose no sangue. Segundo a fabricante, é a primeira medicação com essa atuação dupla a receber aprovação regulatória.
Com a nova liberação, o medicamento poderá ser prescrito para pessoas com obesidade desde que a condição esteja associada a ao menos uma comorbidade, como hipertensão ou dislipidemia. A Anvisa também determinou que a compra da tirzepatida deve seguir protocolos rigorosos, com retenção da receita médica medida que já vale para outras canetas emagrecedoras.
A decisão representa mais uma etapa no avanço dos tratamentos farmacológicos contra a obesidade, condição que atinge quase um quarto da população adulta brasileira, segundo dados do Ministério da Saúde. Especialistas alertam, no entanto, que o uso de medicamentos como o Mounjaro deve ser acompanhado por profissionais de saúde e integrado a mudanças de hábitos alimentares e de atividade física.
A tirzepatida será vendida nas dosagens de 2,5 mg e 5 mg, com caixas contendo quatro canetas. No programa de fidelidade da fabricante, os preços variam entre R$ 1.406,75 (versão de 2,5 mg no e-commerce) e R$ 1.859,65 (versão de 5 mg em loja física). Fora do programa, os valores podem chegar a R$ 2.384,34.
A inclusão do Mounjaro no arsenal contra a obesidade é vista como um avanço por médicos e associações de endocrinologia. Ainda assim, o alto custo do tratamento pode limitar o o para parte significativa da população. Até o momento, não há previsão de inclusão do medicamento no Sistema Único de Saúde (SUS).
 |
 |
